Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light

por Infanti, Laura, Pehlic, Vildana, Mitrovic, Sandra, Holbro, Andreas, Andresen, Silke, Payrat, Jean‐Marc, Lin, Jin‐Sying, Buser, Andreas
Publicado 2022

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia

por Aydinok, Yesim, Piga, Antonio, Origa, Raffaella, Mufti, Nina, Erickson, Anna, North, Anne, Waldhaus, Katie, Ernst, Christine, Lin, Jin‐Sying, Huang, Norman, Benjamin, Richard J., Corash, Laurence
Publicado 2019

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days

por Infanti, Laura, Holbro, Andreas, Passweg, Jakob, Bolliger, Daniel, Tsakiris, Dimitrios A., Merki, Ramona, Plattner, Alexandra, Tappe, David, Irsch, Johannes, Lin, Jin‐Sying, Corash, Laurence, Benjamin, Richard J., Buser, Andreas
Publicado 2019

Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components

por Snyder, Edward L., Wheeler, Allison P., Refaai, Majed, Cohn, Claudia S., Poisson, Jessica, Fontaine, Magali, Sehl, Mary, Nooka, Ajay K., Uhl, Lynne, Spinella, Philip, Fenelus, Maly, Liles, Darla, Coyle, Thomas, Becker, Joanne, Jeng, Michael, Gehrie, Eric A., Spencer, Bryan R., Young, Pampee, Johnson, Andrew, O'Brien, Jennifer J., Schiller, Gary J., Roback, John D., Malynn, Elizabeth, Jackups, Ronald, Avecilla, Scott T., Lin, Jin‐Sying, Liu, Kathy, Bentow, Stanley, Peng, Ho‐Lan, Varrone, Jeanne, Benjamin, Richard J., Corash, Laurence M.
Publicado 2022